We are monitoring the impact of COVID-19 on MEA Genetic Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 25
Share on
Share on

Middle East and Africa Genetic Testing Market Research Report – Segmented By Type, Application and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Size, Share, Growth, Trends, And Forecast (2021 to 2026)

Pulished: April, 2021
ID: 25
Pages: 140

MEA Genetic Testing Market Size (2021 to 2026)

The size of the Genetic Testing Market in the Middle East & Africa was worth USD 3.68 billion in 2021 and is estimated to reach USD 5.07 billion by 2026, growing at a CAGR of 6.64% during the forecast period.

Genetic testing is the most attractive market among the different segments of molecular diagnostics as the need for providing better healthcare is growing. It is the most sophisticated form of medical testing where even the slightest modification in chromosomes, genes, or proteins associated with inherited disease conditions is identified.

The primary reasons for the growth of the genetic testing market are the growing awareness among individuals about the benefits and the potential it has. Some other drivers that aid in the growth of the genetic testing market is innovations in the genetic testing space, an increase in the aging population, a rise in the number of chronic disease cases, and rising incidences of cancer cases.

Genetic testing for cancer is predicted to have a high growth rate and will likely lead the genetic testing market in the near future. The market for new-borns screening, rare and fatal disorders diagnosing and estimating the probability of diseases is expected to expand. Particularly, genetic tests to screen newborns are likely to expand immensely over the coming years. New opportunities for genetic and its related applications are likely to grow due to increasing incidences of genetic diseases. The transformation from a service-driven market to a product-driven market is anticipated to provide a push to the diagnostic companies for expanding their operations.

However, factors such as high costs associated with genetic testing, concerns among the individuals regarding the authenticity of genetic reports due to the credibility of standard procedure are expected to hinder the growth rate of the MEA Genetic Testing Market.

This research report on the MEA Genetic Testing Market has been segmented and sub-segmented into the following categories.

By Application: 

  • Cancer Testing
  • Pharmacogenomics Testing
  • Prenatal Testing
  • Predisposition Testing

By Test: 

  • Carrier Testing
  • Diagnostic Testing
  • Prenatal Testing
  • Neonatal Testing

By Country: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

KEY MARKET PLAYERS:

Companies that are playing a significant role in the MEA Genetic Testing Market profiled in this report are Abbott Laboratories, Roche Molecular Diagnostics Inc., Abbott Molecular Inc., AutoGenomics Inc., Celera Group, ELITech Group, BioRad Laboratories, PerkinElmer Inc., Quest Diagnostics Inc., Transgenomic Inc., and Applied Biosystems Inc.,

1.Introduction                  

                1.1 Market Definition    

                1.2 Study Deliverables  

                1.3 Base Currency, Base Year and Forecast Periods           

                1.4 General Study Assumptions

2. Research Methodology                           

                2.1 Introduction              

                2.2 Analysis Design         

                2.3 Research Phases      

                                2.3.1 Secondary Research

                                2.3.2 Primary Research

                                2.3.3 Econometric Modelling

                                2.3.4 Expert Validation

                2.4 Study Timeline          

3. Overview                      

                3.1 Executive Summary

                3.2 Key Inferences         

                3.3 New Developments

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                      

                4.1 Market Drivers          

                4.2 Market Restraints    

                4.3 Key Challenges         

                4.4 Current Opportunities in the Market

5. Market Segmentation                              

                5.1 By Type        

                                5.1.1 Carrier Testing

                                5.1.2 Diagnostic Testing

                                5.1.3 Prenatal Testing

                                5.1.4 Neonatal Testing

                5.2 By Application           

                                5.2.1 Cancer Testing

                                5.2.2 Prenatal Testing

                                5.2.3 Pharmacogenomics Testing

                                5.2.4 Presdisposition Testing

6. Geographical Analysis                              

                6.1 Introduction              

                6.2 Middle East

                6.3 Africa            

7.Strategic Analysis                        

                7.1 PESTLE analysis         

                                7.1.1 Political

                                7.1.2 Economic

                                7.1.3 Social

                                7.1.4 Technological

                                7.1.5 Legal

                                7.1.6 Environmental

                7.2 Porter’s Five analysis              

                                7.2.1 Bargaining Power of Suppliers

                                7.2.2 Bargaining Power of Consumers

                                7.2.3 Threat of New Entrants

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry

8.Market Leaders' Analysis                          

                8.1 Roche Molecular Diagnostics Inc.      

                                8.1.1 Overview

                                8.1.2 Product Analysis

                                8.1.3 Strategic Evaluation and Operations

                                8.1.4 Financial analysis

                                8.1.5 Legal issues

                                8.1.6 Recent Developments

                                8.1.7 SWOT analysis

                                8.1.8 Analyst View

                8.2 Abbott Laboratories

                8.3 AutoGenomics Inc. 

                8.4 Celera Group             

                8.5 ELITech Group          

                8.6 BioRad Laboratories

                8.7 Quest Diagnostics Inc             

                8.8 Transgenomic Inc.   

                8.9 Applied Biosystems Inc.,       

                8.10 PerkinElmer Inc      

9.Competitive Landscape                            

                9.1 Market share analysis            

                9.2 Merger and Acquisition Analysis        

                9.3 Agreements, collaborations and Joint Ventures          

                9.4 New Product Launches          

10.Expert Opinions                         

                10.1 Market Outlook     

                10.2 Investment Opportunities 

Appendix                           

                a) List of Tables

                b) List of Figures              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East & Africa Genetic Testing Market By Region, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa Carrier Testing Market By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Diagnostic Testing Market By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Neonatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa Cancer Testing Market By Region, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Prenatal Testing Market By Region, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Pharmacogenomics Testing Market By Region, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Predisposition Testing Market By Region, From 2021 to 2026 (USD Billion)
  12. Middle East Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  13. Middle East Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)
  14. Africa Genetic Testing Market By Type, From 2021 to 2026 (USD Billion)
  15. Africa Genetic Testing Market By Application, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample